Q4 2025 AMETEK Inc Earnings Call Transcript
Key Points
- AMETEK Inc (AME) achieved record sales, orders, operating income, EBITDA, and free cash flow in Q4 2025.
- The company reported a 13% increase in sales to $2 billion and an 18% increase in orders, leading to a record backlog of $3.58 billion.
- Operating margins improved to 26.2% with core margins at 27.6%, reflecting strong operational efficiency.
- The acquisition of LKC Technologies expands AMETEK's MedTech exposure, providing new market opportunities.
- AMETEK's Vitality Index, measuring sales of new products, reached 30%, indicating strong innovation and product development.
- The effective tax rate increased to 16.3% in Q4 2025 from 12.8% in the previous year, impacting net income.
- General and administrative expenses rose by $4 million in Q4 due to higher charitable donations.
- The integration of recent acquisitions, such as FARO Technologies, presents challenges with lower initial margins.
- The company faces ongoing macroeconomic uncertainties and sluggish industrial markets.
- Despite strong performance, AMETEK's guidance for 2026 includes only mid- to high single-digit sales growth, indicating potential market challenges.
Good day, and thank you for standing by. Welcome to the Q4 2025 AMETEK Inc., earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your first speaker, Kevin Coleman, VP of Investor Relations and Treasurer. Please go ahead.
Thank you, Crystal. Good morning, and welcome to AMETEK's fourth quarter 2025 earnings conference call. Joining me today are Dave Zapico, Chairman and Chief Executive Officer; and Dalip Puri, Executive Vice President and Chief Financial Officer.
During the course of today's call, we will be making forward-looking statements, which are subject to change based on various risk factors and uncertainties that may cause actual results to differ significantly from expectations. A detailed discussion of the risks and uncertainties that may affect our future results is contained in AMETEK's filings with the SEC. AMETEK disclaims any intention or obligation
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
